Nueva Zelanda -
inglés -
Ministry for Primary Industries
canigen dha2ppi
virbac new zealand limited - canine parvovirus (attenuated); canine adenovirus type 2 (attenuated); canine parainfluenza virus (attenuated); canine distemper virus (attenuated) - canine parvovirus (attenuated) 0 vaccine; canine adenovirus type 2 (attenuated) 0 vaccine; canine parainfluenza virus (attenuated) 0 vaccine; canine distemper virus (attenuated) 0 vaccine - vaccine
Australia -
inglés -
APVMA (Australian Pesticides and Veterinary Medicines Authority)
vanguard c3 injectable live vaccine for dogs
zoetis australia pty ltd - canine distemper virus, strain n-cdv; canine adenovirus type 2, strain manhattan; canine parvovirus, strain nl-35-d; gentamicin - misc. vaccines or anti sera - canine distemper virus, strain n-cdv vaccine-viral active 0.0 p; canine adenovirus type 2, strain manhattan vaccine-viral active 0.0 p; canine parvovirus, strain nl-35-d vaccine-viral active 0.0 p; gentamicin antibiotic other 30.0 ug/ml - immunotherapy
Australia -
inglés -
APVMA (Australian Pesticides and Veterinary Medicines Authority)
protech bronchi-shield iii bordetella bronchiseptica, canine adenovirus type 2 and parainfluenza vaccine
boehringer ingelheim animal health australia pty. ltd. - canine parainfluenza; bordetella bronchiseptica; canine adeno virus type 2 - misc. vaccines or anti sera - canine parainfluenza vaccine active 0.0 p; bordetella bronchiseptica vaccine-microbial active 0.0 p; canine adeno virus type 2 vaccine-viral active 0.0 p - immunotherapy - dog - over 8 weeks - bordetella bronchiseptica | canine adenovirus - type 2 | canine parainfluenza | canine cough syndrome | infectious tracheobronchitis
Reino Unido -
inglés -
VMD (Veterinary Medicines Directorate)
eurican dhppi
boehringer ingelheim animal health uk ltd - canine adenovirus, canine distemper virus, canine parainfluenza virus, canine parvovirus - lyophilisate for suspension for injection - live viral vaccine - dogs
Irlanda -
inglés -
HPRA (Health Products Regulatory Authority)
nobivac parvo-c
intervet ireland limited - canine parvovirus attenuated strain 154 - lyophilisate and solvent for suspension for injection - . - canine parvovirus - dogs - immunological - live vaccine
Irlanda -
inglés -
HPRA (Health Products Regulatory Authority)
vanguard cpv-l.
zoetis belgium s.a. - live canine parvovirus strain nl-35-d; inactivated leptospira canicola; inactivated leptospira icterohaemorrhagiae - solution for injection - . - live canine parvovirus + inactivated leptospira - dogs - immunological - mixed vaccine (l & a)
Australia -
inglés -
APVMA (Australian Pesticides and Veterinary Medicines Authority)
canvac 4+bb combination vaccine pack
zoetis australia pty ltd - bordetella bronchiseptica (inactivated cell free extract; canine adeno virus type 2; canine distemper virus - living; canine parainfluenza virus; canine parvo virus type 2; thiomersal - parenteral liquid/solution/suspension - bordetella bronchiseptica (inactivated cell free extract vaccine-microbial active 0.0 p; canine adeno virus type 2 vaccine-viral active 0.0 p; canine distemper virus - living vaccine-viral active 0.0 p; canine parainfluenza virus vaccine-viral active 0.0 p; canine parvo virus type 2 vaccine-viral active 0.0 p; thiomersal mercury other 0.1 mg/ml - immunotherapy - dog | bitch | castrate | puppy - bordetella bronchiseptica | canine distemper | canine parainfluenza | canine parvovirus | hepatitis :- infectious | canine adenovirus type 1 | canine adenovirus type 2 | canine cough syndrome | infectious canine hepatitis | infectious tracheobronchitis | parvovirus
Nueva Zelanda -
inglés -
Ministry for Primary Industries
vanguard 5
zoetis new zealand limited - canine parvovirus (attenuated); canine distemper virus (attenuated); canine parainfluenza virus (attenuated); canine adenovirus type 2 (attenuated) - canine parvovirus (attenuated) 0 vaccine; canine distemper virus (attenuated) 0 vaccine; canine parainfluenza virus (attenuated) 0 vaccine; canine adenovirus type 2 (attenuated) 0 vaccine - vaccine
Filipinas -
inglés -
FDA (Food And Drug Administration)
hipradog dp formulation: each ml of reconstituted vaccine (dose) contains: canine parvovirus (cpv) (c-780916 strain)->10^7 tcid50 canine distemper (cd) virus (lederle strain)->10^5 tcid50 tcid-tissue culture inleutive dose freeze dried powder for injection (sc)
hipra philippines, inc.; distributor: hipra philippines, inc. - live attenuated canine parvovirus (cpv) , canine distemper virus (cdv) vaccine (vet.) - freeze dried powder for injection (sc) - formulation: each ml of reconstituted vaccine (dose) contains: canine parvovirus (cpv) (c-780916 strain)->10^7 tcid50 canine distemper (cd) virus (lederle strain)->10^5 tcid50 tcid-tissue culture inleutive dose
Filipinas -
inglés -
FDA (Food And Drug Administration)
hipradog dhlp formulation: each ml of reconstituted vaccine (dose) contains: canine parvovirus (c-780916 strain)->10^6 tcid50 canine distemper virus (lederle strain)->10^4 tcid50 canine adenovirus type 2 (manhattan strain)->10^4 tcid50 leptospira interrogans ser. icterohaemorrhagiae->10^9 microorganisms leprospira interrogans ser. canicola toid-tissue culture infactive->10^9 microorganisms freeze dried powder for injection (sc)
hipra philippines, inc.; distributor: hipra philippines, inc. - live attenuated canine parvovirus (cpv) , canine distemper virus (cdv) , canine adenovirus type 2 (cav 2) vaccine , inactivated leptospira interrogans ser. icterohaemorrhagiae , l. interrogans ser. canicola vaccine (vet.) - freeze dried powder for injection (sc) - formulation: each ml of reconstituted vaccine (dose) contains: canine parvovirus (c-780916 strain)->10^6 tcid50 canine distemper virus (lederle strain)->10^4 tcid50 canine adenovirus type 2 (manhattan strain)->10^4 tcid50 leptospira interrogans ser. icterohaemorrhagiae->10^9 microorganisms leprospira interrogans ser. canicola toid-tissue culture infactive->10^9 microorganisms